Inferensys

Glossary

Federated GWAS

A decentralized implementation of a Genome-Wide Association Study that allows biobanks to jointly compute statistical associations between genetic variants and traits without sharing individual-level genotype or phenotype data.
Data scientist building training data pipeline on laptop, data preprocessing visible, technical workspace.
PRIVACY-PRESERVING GENOMICS

What is Federated GWAS?

A decentralized computational framework enabling collaborative genome-wide association studies across multiple biobanks without sharing individual-level genotype or phenotype data.

Federated GWAS is a decentralized implementation of a Genome-Wide Association Study that allows multiple biobanks to jointly compute statistical associations between genetic variants and traits without moving or exposing sensitive individual-level data. Instead of pooling raw genotypes into a central repository, the algorithm dispatches computation to each local site and aggregates only summary-level statistics, preserving patient privacy and complying with data residency regulations.

The architecture typically employs secure aggregation protocols to combine local variant effect sizes and standard errors into a single meta-analysis result. This approach overcomes the statistical power limitations of single-cohort studies while mitigating the legal and ethical barriers that prevent cross-institutional data sharing, making it a cornerstone of privacy-preserving genomic discovery in federated learning for healthcare.

DECENTRALIZED GENOMIC DISCOVERY

Key Features of Federated GWAS

Federated GWAS enables biobanks to jointly compute statistical associations between genetic variants and traits without sharing individual-level genotype or phenotype data. The architecture replaces centralized data pooling with distributed computation and secure aggregation protocols.

01

Privacy-Preserving Allelic Association

The core statistical engine computes allelic odds ratios and chi-squared test statistics locally at each biobank site. Instead of sharing raw genotypes, sites transmit only aggregate summary statistics—allele counts and contingency table margins—to a central analyst. This preserves the mathematical equivalence of a pooled mega-analysis while ensuring that no individual-level variant calls ever leave the originating institution's secure enclave.

02

Distributed Logistic Regression

For quantitative trait analysis, federated GWAS employs iteratively reweighted least squares executed across sites. Each biobank computes local gradient updates on its own genotype-phenotype matrices, and a central server aggregates these updates using Federated Averaging (FedAvg). This approach handles covariates such as age, sex, and principal components without exposing patient-level confounders, enabling adjusted association testing at genome-wide scale.

03

Secure Meta-Analysis Aggregation

The central aggregation node combines site-level summary statistics using inverse-variance weighted meta-analysis methods, including fixed-effects and random-effects models. To prevent gradient leakage or allele frequency reconstruction attacks, the system integrates Secure Aggregation protocols and optional Differential Privacy noise injection. The result is a single set of p-values and effect sizes statistically identical to what would be obtained from a pooled dataset.

04

Cross-Site Allele Harmonization

A critical preprocessing layer resolves strand ambiguity and reference allele mismatches across genotyping platforms and imputation panels. The system performs distributed allele frequency checks and LD-based variant matching to ensure that effect alleles are consistently oriented across all participating biobanks before association testing begins. This prevents spurious heterogeneity that would otherwise inflate genomic control lambda values.

05

Heterogeneous Phenotype Alignment

Federated GWAS addresses Non-IID phenotype distributions across sites by implementing distributed cohort discovery and phenotype harmonization ontologies. Each site maps its local electronic health record codes to a common data model using standardized terminologies such as SNOMED CT and ICD-10. The system validates phenotype definitions through federated cohort counts before launching full association scans, ensuring consistent case-control definitions.

06

Byzantine-Resilient Quality Control

To guard against data poisoning attacks and inadvertent protocol violations, the system applies Byzantine Fault Tolerance principles to quality control. Site-level summary statistics are tested for deviation from expected genomic inflation factors and allele frequency distributions. Outlier sites exhibiting anomalous test statistics are flagged and can be excluded from meta-analysis, ensuring that a single misconfigured biobank cannot corrupt the global association results.

FEDERATED GWAS EXPLAINED

Frequently Asked Questions

Clear, technical answers to the most common questions about decentralized genome-wide association studies, covering architecture, privacy guarantees, and practical implementation considerations for multi-site biobank networks.

Federated GWAS is a decentralized implementation of a Genome-Wide Association Study that enables multiple biobanks to jointly compute statistical associations between genetic variants and phenotypic traits without sharing individual-level genotype or phenotype data. The architecture operates by distributing computation to each participating site, where local summary statistics—such as allele frequencies, effect sizes, and standard errors—are calculated behind institutional firewalls. A central aggregation server then combines these local summary statistics using meta-analysis techniques like inverse-variance weighting or the Mantel-Haenszel method to produce a single, global set of association results. Critically, only aggregated statistics ever leave a site, ensuring that raw patient-level data remains under the control of the originating institution. This approach transforms the traditional GWAS workflow from a data-centralization paradigm to a compute-to-data paradigm, enabling studies of unprecedented scale across previously siloed biobanks while satisfying the strict data governance requirements of healthcare regulations like HIPAA and GDPR.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.